Advanced Search
MAO Mingfeng, YANG Shunshi, XIE Yuanliang, SUN Lin, LU Hui, YUAN Jingping. Comparative Study on Color Doppler Ultrasonography and Digital Mammography in Diagnosis of Breast Ductal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 370-373. DOI: 10.3971/j.issn.1000-8578.2014.04.019
Citation: MAO Mingfeng, YANG Shunshi, XIE Yuanliang, SUN Lin, LU Hui, YUAN Jingping. Comparative Study on Color Doppler Ultrasonography and Digital Mammography in Diagnosis of Breast Ductal Carcinoma[J]. Cancer Research on Prevention and Treatment, 2014, 41(04): 370-373. DOI: 10.3971/j.issn.1000-8578.2014.04.019

Comparative Study on Color Doppler Ultrasonography and Digital Mammography in Diagnosis of Breast Ductal Carcinoma

More Information
  • Received Date: March 10, 2013
  • Revised Date: April 17, 2013
  • Objective To investigate the value of color doppler ultrasonography(CDUS) and digital mammography in diagnosis of breast ductal carcinoma. Methods CDUS and digital mammography results of 73 nidi from 73 patients diagnosed as DCIS by postoperative pathological results were retrospectively analyzed. The value of CDUS, digital mammography, separately and the combination in the diagnosis of DCIS were compared. Results Forty-eight nidi were diagnosed as DCIS. The sensitivity of CDUS and digital mammography was 66.67% (32/48) and 70.83% (34/48) respectively, there was no statistical signifi cance(P>0.05), and the specifi city was 90.32% and 80.65 % respectively, the positive predictive value was 91.43% and 85.00% respectively and the negative predictive value was 63.64% and 64.10% respectively. The sensitivity of the combination was 95.83% (46/48). The difference between the combination and CDUS or digital mammography alone had statistical signifi cance (P<0.05). Conclusion CDUS has higher detection rate in internal structure and peripheral duct disorder but lower detection rate in microcalcifi cation of DCIS than digital mammography. The combination could improve the accuracy of DCIS diagnosis.
  • [1]
    Zhou HH, Xu QH, Yan S. Ultrasonographic diagnosis of breast ductal carcinoma in situ[J]. Zhongguo Chao Sheng Yi Xue Za Zhi, 20 08, 24(4):367-9.[周辉红,徐秋华,燕山. 乳腺导管内癌的超声 研究[J] 中国超声医学杂志,2008,24(4):367-9.]
    [2]
    Zhu QL, Jiang YX, Liu H, et al. Initial experiences of diagnosis on the non-invasive breast cancer: comparison of conventional ultrasound and real-time elastography[J]. Zhongguo Yi Xue Ying Xiang Ji Shu,2008,2(4):683-6.[朱庆莉,姜玉新,刘赫,等.常规超声 结合超声弹性成像对乳腺导管内癌诊断的初步探讨[J].中国医 学影像技术,2008,24(5):683-6.]
    [3]
    Li XM ,LI YH ,Tian JM,et al. Evaluation of peripheral artery stent with 64-slice multi-detector row CT angiography: prospective comparison with digital subtraction angiography[J]. Eur J Radiol, 20 10,75(1):98-103.
    [4]
    Khoo ML, Asa SL,Writterick IJ,et al. Thyroid calcification and its association with thyroid carcinoma [J]. Head Neck,2002 ,24 (7) :651-5.
    [5]
    Xie F, Zhou B, Yang DQ, et al. Value of mammography and ultrasonography in diagnosis of breast ductal carcinoma in situ[J]. Zhongguo Yi Xue Ying Xiang Ji Shu,2012,28(7):1314-7.[谢菲,周 波,杨德起,等.钼靶X线及超声在乳腺导管原位癌诊断中的价 值[J] 中国医学影像技术,2012,28(7):1314-7.]
    [6]
    Fischer U, Baum F,Obenauer S, et al.Comparative study in patients with microcalcifications:full-field digital mammography vs screen-fi lm mammography[J]. Eur Radiol,2002,12(11):2679-83.
    [7]
    Xu P, Hua XY, Shan JL, et al. High-frequency ultrasonographic evaluation of breast microcalcification[J]. Zhongguo Yi Xue Ji Suan Ji Cheng Xiang Za Zhi, 2003,9(4):290-2.[许萍,华秀云,单洁 玲,等. 乳腺微小钙化灶的高频超声声像图评价[J].中国医学计 算机成像杂志,2003,9(4):290-2.]
    [8]
    Li HL, Jiang YX, Hao YZ, et al. Comparison results of breast ultrasound, mammography and combination of both modalities[J], Zhonghua Chao Sheng Ying Xiang Xue Za Zhi,2006,15(12):910-3.[李洪林,姜玉新,郝玉芝,等.乳腺超 声与钼靶摄影的比较与联合应用[ J ] .中华超声影像学杂 志,2006,15(12):910-3.]
    [9]
    Leconte I,Feger C,Galant C,et al. Mammography and subsequent whole-breast sonography of nonpalpable breast cancers: the importance of radiologic breast density[J]. AJR Am J Roentgenol, 20 03,180(6):1675-9.
    [10]
    Crystal P,Strano S,Shcharynski S,et al. Using sonography to screen women with mammographically dense breasts[J]. AJR Am J Roentgenol,2003,181(7):177-82.
    [11]
    Zonderland HM,Coerkamp EG, Hermans J,et al. Diagnosis of breast cancer: contribution of US as an ajunct to mammography[J]. Radiology,1999,213(2):413-22.
    [12]
    Innos K,Horn-Ross PL. Risk of second primary breast cancers among women with ductal carcinoma in situ of the breast[J]. Breast Cancer Res Treat,2008,111(3):531-40.
    [13]
    Zhang WX, Jiang WY, Dai WJ, et al. [J]. Clinical characteristics and selection of surgical treatment of ductal carcinoma in situ[J]. Zhonghua Nei Fen Mi Wai Ke Za Zhi,2012, 6(2):112-3,116.[张伟 欣,姜文玉,代文杰,等.乳腺导管内癌临床特点与外科治疗的选 择[J] 中华内分泌外科杂志,2012,6(2):112-3,116.]
  • Related Articles

    [1]HE Yang, YANG Runfeng, ZHOU Yingying, XU Qian, YAN Hao, JIANG Lei, JIANG Xiaohui, HUANG Yi. Effect of Aprepitant on Chemotherapy-induced Adverse Reactions in Gynecological Malignancy Patients[J]. Cancer Research on Prevention and Treatment, 2018, 45(11): 913-916. DOI: 10.3971/j.issn.1000-8578.2018.18.0265
    [2]LI Daojun, XU Xinhua, ZHANG Jianyu, LI Cong. Clinical Observation of Olanzapine in Treatment of Nausea and Vomiting Caused by Opioid Analgesics[J]. Cancer Research on Prevention and Treatment, 2018, 45(5): 326-328. DOI: 10.3971/j.issn.1000-8578.2018.17.1275
    [3]DONG Shuang, WANG Jun, HU Sheng, LIAO Guoxiang, RAN Fengming. Aprepitant versus Olanzapine for Prevention of Nausea and Vomiting Induced by Multi-day Chemotherapy in Female Lung Cancer or Breast Cancer Patients[J]. Cancer Research on Prevention and Treatment, 2017, 44(5): 356-359. DOI: 10.3971/j.issn.1000-8578.2017.05.009
    [4]LI Quanfu, Jin gaowa, WANG Wenjuan, JIANG Caihong, DENG Shuqin, LI Hui, CHEN Feng, BAI Xiaojun, CHEN Gang, HU Yuliang, ZHAO Jun, Dalenggaowa, Wuyungaowa. Clinical Observation of Neurokinin-1 Antagonist Preventing Multiple-day Chemotherapy-induced Nausea and Vomiting[J]. Cancer Research on Prevention and Treatment, 2017, 44(4): 290-294. DOI: 10.3971/j.issn.1000-8578.2017.04.011
    [5]LV Minhao, QIN Li, LI Juntao, GUO Xuhui, LIU Fawen, CUI Shude, ZHANG Hengwei. 原发性乳腺癌分子分型与新辅助化疗疗效及预后的相关性[J]. Cancer Research on Prevention and Treatment, 2015, 42(08): 782-788. DOI: 10.3971/j.issn.1000-8578.2015.08.007
    [6]DONG Shuang, YU Shiying. A Study of Chemotherapy-induced Nausea and Vomiting Involving Different Dosage Regimens of Cisplatin[J]. Cancer Research on Prevention and Treatment, 2013, 40(09): 890-893. DOI: 10.3971/j.issn.1000-8578.2013.09.016
    [7]Xu Lu, Li Chunlai, Li Ling. A Constructive Experimental Study on Prevention of Chemotherapy-induced Nausea and Vomiting by Ginger-partitioned Moxibustion on Acupoint of Zusanli[J]. Cancer Research on Prevention and Treatment, 2012, 39(06): 710-712. DOI: 10.3971/j.issn.1000-8578.2012.06.024
    [8]XU Shu, LI Hong, SONG Yu-hong, LI Bin, CAI Hong-bing. Clinical Comparative of Tropisetron Hydrochloride with or without Traditional Chinese Medicine Compound in Prevention of Chemotherapy-induced Nausea and Emesis[J]. Cancer Research on Prevention and Treatment, 2009, 36(09): 787-790. DOI: 10.3971/j.issn.1000-8578.2009.09.021
    [9]MA Lei, MA Hai-long, ZHAO Xu-lin, et al. A Clinical Observation of Tropisetron in Combination with Dexame thasone and Methclopramide in the prevention of High Dose Cisplatin- induced Delayed Nausea and Emesis[J]. Cancer Research on Prevention and Treatment, 2001, 28(06): 469-470. DOI: 10.3971/j.issn.1000-8578.474
    [10]Chen Zhendong, . Medroxyprogesterone Acetate with Antiemetics: Efficacy in ControllingAnorexia, Nausea and Vomiting Induced by Chemotherapy[J]. Cancer Research on Prevention and Treatment, 1996, 23(2): 102-103.

Catalog

    Article views (1347) PDF downloads (373) Cited by()

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return